Overslaan naar content

Postdoc - Molecular Oncology & Immunology

    • Amsterdam

Job description

The Daniel Peeper Group at the Netherlands Cancer Institute is seeking an ambitious postdoctoral researcher with a strong background in immunology and cancer biology to join an exciting international project exploring the "dark peptidome" as a new source of targets for cancer immunotherapy. You will contribute to the discovery and validation of novel tumor-restricted antigens, helping to advance next-generation TCR-based therapies for cancer patients.

Cancer immunotherapy has been transformed by checkpoint inhibitors and adoptive cell therapies, but remains limited by the scarcity of validated, tumor-specific antigens. Mutation-derived neoantigens and overexpressed self-proteins are often low in number, weakly immunogenic and carry cross-reactivity risk, leaving patients with a low tumor mutational burden with little benefit. In an international collaboration we are starting a project that instead aims to discover immune reactivity towards the tumor “dark peptidome”: cryptic antigens that arise by non-canonical errors. They are presented on MHC molecules, but are absent from normal tissue. Being tumor-restricted and potentially shared between patients, these dark peptides are attractive targets for T cell receptor (TCR)-based therapy. Among several advanced technologies, we will use the heterotypic T cell:tumor cell clusters we recently reported (1). Identified lead TCRs will be engineered and validated in preclinical models.

Your profile

We seek a highly ambitious postdoc with a strong background in immunology and cancer biology, and an interest in both fundamental and translational cancer research. Experience with corresponding technologies including flow cytometry, cell culture, CRISPR screening, (single-cell) sequencing, and in vivo tumor models is an advantage. Your responsibilities will include writing of manuscripts and grant applications, as well as close interaction with our international partners. Proficiency in English and good communicative skills are important requirements, as is a team player mentality.

Why the Netherlands Cancer Institute?

Science is at the heart of everything we do at the NKI. But breakthroughs don't happen through science alone; they happen through people – curious minds, bold thinkers, people who challenge assumptions and turn complex questions into meaningful discoveries. Around 600 scientists, together with 150 scientific and 150 administrative professionals, work here across the full spectrum of cancer research, from fundamental science to clinical innovation. With roughly 55 nationalities represented, we form a vibrant international community where English is our shared language and every voice carries equal weight. Our institute sits just 15 minutes by bike from the heart of Amsterdam.

Your development opportunities and employment conditions

The basis for your employment conditions is in accordance with the CLA Hospitals. You will receive from us:

  • A contract for 4 years, for 36 hours per week. Starting date will be in the spring of 2027;

  • A gross monthly salary between € 4.629,- and € 5.503,-, based on a 36-hour working week, in line with FWG 55 and depending on your experience;

  • 144 holiday hours and 57 hours of Personal Life Budget, with full-time employment;

  • Annual holiday pay of 8.33% and a fixed end-of-year bonus of 8.33%;

  • A travel allowance of €0.23 per km;

  • Free parking at the Netherlands Cancer Institute. And with our bicycle plan and discount on public transport we also make it attractive for you to leave the car at home;

  • Discounted sports memberships through Fit Boutiqs and 25% off a TrainMore membership;

  • An active staff association.

Interested?

We are curious about your talent! Will you be the one to make a difference in the world of cancer care and research? Apply now by using the application button; via email will not be considered. Applications should include your CV, motivation letter and the contact information of at least two references. Please make sure to include your reference information together with your application documents, as there is no option to submit them separately.

For further information about the position, please contact Daniel Peeper via d.peeper@nki.nl or click here to learn more about his research group. For questions about the application procedure, please contact Daphne Heemskerk (Recruiter) via d.heemskerk@nki.nl.

This vacancy will remain open until we have found a suitable candidate. We will review applications and conduct interviews on a rolling basis, so we encourage interested candidates to apply as soon as possible.

Select reading

(1) Ibáñez-Molero*, Veldman* et al, Tumour-reactive heterotypic CD8 T cell clusters from clinical samples. Nature 2026

or

On-site
  • Amsterdam